Literature DB >> 1543544

Murine p53 intron sequences 5-8 and their use in polymerase chain reaction/direct sequencing analysis of p53 mutations in CD-1 mouse liver and lung tumors.

T L Goodrow1, R D Storer, K R Leander, S R Prahalada, M J van Zwieten, M O Bradley.   

Abstract

Inactivating point mutations and small deletions in the p53 tumor suppressor gene have been found in human liver and lung tumor--derived cell lines and tumors. However, little evidence has been reported concerning inactivation or mutation of the p53 gene in mouse primary tumors. To examine CD-1 mouse liver and lung tumors for mutations in the p53 gene, we first sequenced p53 introns 5-8 so that polymerase chain reaction amplification and sequencing primers located within the introns could be prepared. Use of these primers prevented amplification of the mouse p53 pseudogene and allowed sequencing of exons 5-8 in their entirety as well as their intron-exon junctions. DNA isolated from CD-1 mouse tumors was amplified and directly sequenced using nested primers. Nine spontaneous hepatocellular carcinomas (HCCs) and 34 chemically induced HCCs (induced by single intraperitoneal injections of N-nitrosodiethylamine [DEN] [8 HCCs], 7,12-dimethylbenz[a]anthracene [DMBA] [8 HCCs], 4-aminoazobenzene [8 HCCs], and N-OH-2-acetylaminofluorene [10 HCCs]) were examined for mutations in exons 5-8 of the p53 gene. In addition, 12 spontaneous, 10 DMBA-induced, and 13 DEN-induced lung adenocarcinomas or adenomas were analyzed for mutations. No mutations were found in any of the tumors examined. However, a mutation was demonstrated at codon 135 in the positive-control plasmid LTRp53cG(val). The results of this study suggest that inactivation of p53 is unlikely to play a major role in murine lung or liver carcinogenesis. However, inactivation of p53 may occur at a very low frequency, or it may occur as a late event and therefore be present in only a very small number of the tumor cells, rendering it undetectable by this method. Lastly, although few p53-inactivating mutations are found outside of exons 5-8 in human tumors, it is possible that these murine tumors contained mutations outside of this region and were therefore missed by our approach.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1543544     DOI: 10.1002/mc.2940050105

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  8 in total

1.  New assays for Y chromosome and p53 pseudogene clines among East Holstein house mice.

Authors:  E M Prager; P Boursot; R D Sage
Journal:  Mamm Genome       Date:  1997-04       Impact factor: 2.957

2.  Cis lethal genetic interactions attenuate and alter p53 tumorigenesis.

Authors:  Yuxun Wang; Weijia Zhang; Lisa Edelmann; Richard D Kolodner; Raju Kucherlapati; Winfried Edelmann
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-08       Impact factor: 11.205

3.  Distribution of the p53 pseudogene among mouse species and subspecies.

Authors:  H Tanooka; A Ootsuyama; T Shiroishi; K Moriwaki
Journal:  Mamm Genome       Date:  1995-05       Impact factor: 2.957

4.  Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants.

Authors:  M G Rizzo; S Soddu; G Tibursi; B Calabretta; A Sacchi
Journal:  Clin Exp Metastasis       Date:  1993-09       Impact factor: 5.150

5.  Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.

Authors:  R W Wiseman; C Cochran; W Dietrich; E S Lander; P Söderkvist
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene.

Authors:  B Ruggeri; M DiRado; S Y Zhang; B Bauer; T Goodrow; A J Klein-Szanto
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Alterations in the K-ras and p53 genes in rat lung tumors.

Authors:  S A Belinsky; D S Swafford; G L Finch; C E Mitchell; G Kelly; F F Hahn; M W Anderson; K J Nikula
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  Hydroquinones cause specific mutations and lead to cellular transformation and in vivo tumorigenesis.

Authors:  P Joseph; A J Klein-Szanto; A K Jaiswal
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.